{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T09:23:30Z","timestamp":1768555410387,"version":"3.49.0"},"reference-count":7,"publisher":"Cambridge University Press (CUP)","issue":"1","license":[{"start":{"date-parts":[[2016,2,17]],"date-time":"2016-02-17T00:00:00Z","timestamp":1455667200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":["journals.cambridge.org"],"crossmark-restriction":true},"short-container-title":["Powder Diffr."],"published-print":{"date-parts":[[2016,3]]},"abstract":"<jats:p>\n                    X-ray powder diffraction data, unit-cell parameters, and space group for olmesartan medoxomil, C29H30N6O6, are reported [\n                    <jats:italic>a<\/jats:italic>\n                    = 12.3969(7) \u00c5,\n                    <jats:italic>b<\/jats:italic>\n                    = 21.2667(3) \u00c5,\n                    <jats:italic>c<\/jats:italic>\n                    = 10.9603(5) \u00c5,\n                    <jats:italic>\u03b1<\/jats:italic>\n                    =\n                    <jats:italic>\u03b3<\/jats:italic>\n                    = 90\u00b0,\n                    <jats:italic>\u03b2<\/jats:italic>\n                    = 101.38(9)\u00b0, unit-cell volume\n                    <jats:italic>V<\/jats:italic>\n                    = 2832.72 \u00c53,\n                    <jats:italic>Z<\/jats:italic>\n                    = 4 and space group\n                    <jats:italic>P<\/jats:italic>\n                    2\n                    <jats:sub>\n                      1\/\n                      <jats:italic>c<\/jats:italic>\n                    <\/jats:sub>\n                    ]. All measured lines were indexed and are consistent with the\n                    <jats:italic>P<\/jats:italic>\n                    2\n                    <jats:sub>\n                      1\/\n                      <jats:italic>c<\/jats:italic>\n                    <\/jats:sub>\n                    space group. No detectable impurities were observed.\n                  <\/jats:p>","DOI":"10.1017\/s0885715615000925","type":"journal-article","created":{"date-parts":[[2016,2,17]],"date-time":"2016-02-17T04:32:11Z","timestamp":1455683531000},"page":"73-76","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":0,"title":["X-ray powder diffraction data for olmesartan medoxomil, C\n                    <sub>29<\/sub>\n                    H\n                    <sub>30<\/sub>\n                    N\n                    <sub>6<\/sub>\n                    O\n                    <sub>6<\/sub>"],"prefix":"10.1154","volume":"31","author":[{"given":"Xiaochun","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peixiao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanshan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kailin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2016,2,17]]},"reference":[{"key":"S0885715615000925_ref6","doi-asserted-by":"publisher","DOI":"10.1017\/S0885715613000742"},{"key":"S0885715615000925_ref7","doi-asserted-by":"publisher","DOI":"10.1017\/S0885715613000067"},{"key":"S0885715615000925_ref5","doi-asserted-by":"publisher","DOI":"10.2165\/00129784-200505010-00006"},{"key":"S0885715615000925_ref2","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1021\/jm950450f","article-title":"Nonpeptide angiotensin II receptor antagonists: synthesis, biological activities, and structure-activity relationships of imidazole-5-carboxylic acids bearing alkyl, alkenyl, and hydroxyalkyl substituents at the 4-position and their related compounds","volume":"39","author":"Hiroaki","year":"1996","journal-title":"J. Med. Chem"},{"key":"S0885715615000925_ref4","first-page":"141","article-title":"Redetermination of the structure of olmesartan medoxomil, (5-methyl-2-oxo-2H-1,3-dioxol-4-yl)-methyl-4-(2-hydroxypropan-2-yl)-2-propyl-1-(-[2-(2H-1,2,3,4-tetrazol-5-yl)-phenyl]phenylmethyl)-1H-imidazole-5-carboxylate, C29H30N6O6","volume":"228","author":"Richard","year":"2013","journal-title":"Z. Kristallogr. NCS"},{"key":"S0885715615000925_ref1","doi-asserted-by":"publisher","DOI":"10.1107\/S0021889899009930"},{"key":"S0885715615000925_ref3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0014-2999(95)00401-6","article-title":"Pharmacology of CS-866, a novel nonpeptide angiotensin II receptor antagonist","volume":"285","author":"Makoto","year":"1995","journal-title":"Eur. J. Pharmacol"}],"container-title":["Powder Diffraction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0885715615000925","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T14:59:44Z","timestamp":1768489184000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0885715615000925\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,17]]},"references-count":7,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0885715615000925"],"URL":"https:\/\/doi.org\/10.1017\/s0885715615000925","relation":{},"ISSN":["0885-7156","1945-7413"],"issn-type":[{"value":"0885-7156","type":"print"},{"value":"1945-7413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,17]]},"assertion":[{"value":"Copyright \u00a9 International Centre for Diffraction Data 2016\u00a0","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}}]}}